Cadex Genomics·Apr 16, 2020Molecular Diagnostics: A Broken Business Model or Flawed Execution?It is common to hear concerns from investors and other stakeholders about the business case for molecular diagnostics. One life science…
Cadex Genomics·May 10, 2019The Case for Real-Time Cancer Therapy MonitoringMost stage IV cancer patients ultimately die from their disease. For late-stage cancer patients, the primary medical treatment objective…